运动专家对帕金森病患者的机器人引导康复运动的评估
Matthew Lamsey1, Meredith D Wells2, Lydia Hamby3
1Georgia Institute of Technology, Institute for Robotics and Intelligent Machines, Atlanta, GA 30332, USA.
Healthcare (Basel, Switzerland)
|July 12, 2025
概括
运动专家发现了一种新的机器人主导系统,对帕金森病有益.
科学领域:
- 康复工程 康复工程 康复工程
- 人与机器人的交互
- 神经康复 神经康复 神经康复
背景情况:
- 机器人主导的运动系统可以增强运动专家 (ESs) 的护理.
- 医疗服务提供者 (ES) 规定练习以提高患者的坚持,特别是在家庭计划中.
- 开发个性化机器人系统需要机器人学家,ES和患者之间的合作.
研究的目的:
- 从ESs的角度评估一种新型机器人主导的帕金森病 (PD) 患者炼系统的有效性和接受度.
- 收集ES经验和对机器人系统可用性和有效性的感知.
主要方法:
- 一个试点用户研究涉及11个ESs.
- 混合方法方法:技术验收问卷,任务负载问卷和半结构面试.
- ES与专为PD患者设计的机器人主导的炼系统进行了交互.
主要成果:
- 欧洲经济学家报告说,该系统的接待普遍是积极的.
- 该系统显示了增强PD康复的潜力,改善患者参与度,并确保一致的运动支持.
- 改进的关键领域包括更多类似人类的反和提高机器人的易用性.
结论:
- 机器人助理在增加PD的康复运动方面具有重要价值.
- 这些发现为开发更有效,更易于使用的康复技术提供了指导.
- 涉及ESs的以用户为中心的设计对于成功整合康复中的技术至关重要.
更多相关视频
05:25Author Spotlight: Assessing Brain Activity in Robotic-Assisted Lower Limb Rehabilitation Using fNIRS
Published on: June 7, 2024
1.4K
06:00A Rehabilitation Program of Exoskeleton-assisted Body Weight-Supported Treadmill Training with Non-immersive Virtual Reality for Stroke Patients
Published on: May 16, 2025
390
相关概念视频
01:24Parkinson's Disease: Treatment
385
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
385
01:15Parkinson's Disease: Overview
715
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
715